Northwest Biotherapeutics, Inc. v. Canaccord Genuity LLC

FNDORSED KASOWITZ LLP October 16, 2025 Hon. Gary Stein, U.S.M.J. United States District Court, Southern District of New York Re: | Northwest Biotherapeutics, Inc. vy. Canaccord Genuity LLC, No. 1:22-cv-10185 Dear Judge Stein: We represent Plaintiff Northwest Biotherapeutics, Inc. We write in response to Defendants’ letter motion to compel Plaintiff to produce calculations of trading data underlying the Second Amended Complaint (“SAC”). Defendants’ letter is just their latest attempt to force discovery of work product—here, mathematical analyses of the data—from Plaintiff's non-testifying…